AU2003264265A1 - Method for the local detection of inflammation and allergy mediators - Google Patents

Method for the local detection of inflammation and allergy mediators

Info

Publication number
AU2003264265A1
AU2003264265A1 AU2003264265A AU2003264265A AU2003264265A1 AU 2003264265 A1 AU2003264265 A1 AU 2003264265A1 AU 2003264265 A AU2003264265 A AU 2003264265A AU 2003264265 A AU2003264265 A AU 2003264265A AU 2003264265 A1 AU2003264265 A1 AU 2003264265A1
Authority
AU
Australia
Prior art keywords
interleukin
inflammation
allergy mediators
local detection
mediators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264265A
Inventor
Ernst Rainer Weissenbacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDIFACT-PUBLISHING GmbH
Original Assignee
MEDIFACT PUBLISHING GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002141700 external-priority patent/DE10241700A1/en
Application filed by MEDIFACT PUBLISHING GmbH filed Critical MEDIFACT PUBLISHING GmbH
Publication of AU2003264265A1 publication Critical patent/AU2003264265A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Abstract

The invention relates to a method for the local qualitative or quantitative detection of inflammation and/or allergy mediators using PCR (polymerase chain reaction), LCR (ligase chain reaction) and/or enzymatic assay or radioimmunoassay in a sample. Said method is characterised in that the sample is a vaginal smear, secretion or a vaginal irrigation. Preferably, the inflammation and/or allergy mediators are cytokines, in particular tumour necrosis factors, interferon- gamma , interleukin-1, interleukin-1ra, interleukin-2, interleukin-4, interleukin-6, interleukin-10 and interleukin-12 and prostaglandins and leukotrienes.
AU2003264265A 2002-09-09 2003-09-04 Method for the local detection of inflammation and allergy mediators Abandoned AU2003264265A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40928702P 2002-09-09 2002-09-09
DE10241700.8 2002-09-09
DE2002141700 DE10241700A1 (en) 2002-09-09 2002-09-09 Local determination of inflammatory and allergic mediators in vaginal fluid, useful for diagnosis of infections, immune defects, inflammation and allergy
US60/409,287 2002-09-09
PCT/EP2003/009841 WO2004025304A1 (en) 2002-09-09 2003-09-04 Method for the local detection of inflammation and allergy mediators

Publications (1)

Publication Number Publication Date
AU2003264265A1 true AU2003264265A1 (en) 2004-04-30

Family

ID=31995053

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264265A Abandoned AU2003264265A1 (en) 2002-09-09 2003-09-04 Method for the local detection of inflammation and allergy mediators

Country Status (5)

Country Link
EP (1) EP1537423B1 (en)
AT (1) ATE328284T1 (en)
AU (1) AU2003264265A1 (en)
DE (1) DE50303607D1 (en)
WO (1) WO2004025304A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009063307A2 (en) * 2007-11-14 2009-05-22 Bio-Technology General (Israel) Ltd. Inflammatory activity detection method using il-6

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190872B1 (en) * 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
US5589344A (en) * 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay
WO2002022803A2 (en) * 2000-09-12 2002-03-21 Zycos Inc. Peptide epitopes recognized by antigen specific cd4+ t lymphocytes
EP1387694A2 (en) * 2001-05-09 2004-02-11 M'S Science Corporation Composition and method for treating cancer using herpes virus

Also Published As

Publication number Publication date
EP1537423A1 (en) 2005-06-08
EP1537423B1 (en) 2006-05-31
DE50303607D1 (en) 2006-07-06
WO2004025304A1 (en) 2004-03-25
ATE328284T1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
WO2003001697A3 (en) Reducing the peak-to-average power ratio of a communication sign al
ATE475223T1 (en) DEVICE FOR REDUCING TRANSMITTER POWER REQUIREMENT USING DUAL MATRICES, AND METHOD THEREOF
EP2348535A3 (en) Method and Apparatus for Use in Improving Linearity of MOSFETS Using an Accumulated Charge Sink
WO2003038070A1 (en) Base material for culturing embryo stem cells and culture method
WO2002071713A3 (en) Compensation of distortion due to channel and to receiver, in a parallel transmission system
EP2596948A3 (en) Method of making a semiconductor device
WO2003060653A3 (en) Method and/or system for analyzing biological samples using a computer system
ATE499751T1 (en) WIRELESS RECEIVER AND METHOD FOR SAVING POWER
DK1535068T3 (en) Devices and methods for the detection of amniotic fluid in vaginal secretions
EP1369196B8 (en) Slide saw and method of using the same
AU2003294474A1 (en) Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
WO2004060291A3 (en) Uses of mammalian cytokine; related reagents
AU2003217105A1 (en) Novel of cytokine inhibitors
AU2003264265A1 (en) Method for the local detection of inflammation and allergy mediators
GB2372398B (en) Automatic detector of media interface protocol type
AU2003238215A1 (en) Novel interleukin-1 beta converting enzyme inhibitors
AU2003242364A1 (en) Particulate aluminum nitride and method for production thereof
EP1334953A3 (en) Method and apparatus for severing sheets of glass
WO2003068152A3 (en) Purified cytokine inhibitory factor
AU4397101A (en) Method and kit for the detection of schistosomiasis through the polymerase chainreaction
EP1271810A3 (en) Method and device for shaping the waveform of an optical signal
MY136188A (en) Method of affixing a pre-formed gasket and gasket used therefor
EP1493884A3 (en) Beam profile and roofing profile
WO2003031969A1 (en) Novel method of assaying immune activity
AU2003243266A1 (en) Method of reducing incidence diabetic embryopathy with l-ergothioneine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase